292 Matches for Grotenhuis

What is Grotenhuis's Instagram?

We've discovered several social media accounts associated with Grotenhuis, including @grotenhuis, @cedarlakecrush, @lea_tegrotenhuis, @jeffgrotenhuis and others. To explore more of Grotenhuis's online presence, click here.

What is Grotenhuis's Facebook?

We've discovered several social media accounts associated with Grotenhuis, including @toos.grotenhuis.319, @shad.grotenhuis, @brett.grotenhuis, @isaac.grotenhuis and others. To explore more of Grotenhuis's online presence, click here.

What is Grotenhuis's famous for?

Peter Grootenhuis was a Dutch-American Medicinal Chemist. Grootenhuis was the Project Leader and Co-Inventor of Ivacaftor (VX-770), the first CFTR potentiator FDA approved drug to treat the underlying cause of Cystic Fibrosis (CF) in patients with certain mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene, who account for 4-5% of CF cases. Grootenhuis also led the Vertex team to subsequent discovery of Orkambi, the combination of Ivacaftor and Lumacaftor(VX-809), approved to treat CF in people with two copies of the F508del mutation. Most recently, Grootenhuis's team discovered Tezacaftor (VX-661) and Elexacaftor (VX-445), which in combination with Ivacaftor are the components of Trikafta, a drug approved by the FDA in 2019 to treat CF in more than 90% of CF patients. For Grootenhuis’ contributions to the discovery of these compounds, he was awarded the 2018 IUPAC Richter Prize, the American Chemical Society’s 2013 Heroes of Chemistry Award, and inducted into the American Chemical Society Division of Medicinal Chemistry Hall of Fame. Grootenhuis has contributed to the discovery of over 11 clinical candidates, co-authored more than 100 peer reviewed papers and is inventor of 65 + U.S Patents, and more than 50 EU Patents.. You can find more here.

Are PeekYou social results accurate?

PeekYou is a free people-focused search engine that uncovers information typically buried by other search engines. Its clean and user-friendly format makes it easy to navigate. The platform offers accurate data and conveniently links to an individual's social media profiles and other public websites with which they are associated.